Australian CVD Risk Calculator
Iteration3 - ci-build

Australian CVD Risk Calculator - Local Development build (vIteration3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

## : Aus CVD Risk Blood Pressure Lowering Medicine - JSON Representation

Draft as of 2025-05-19

Raw json | Download

    {
      "resourceType" : "ValueSet",
      "id" : "AusCVDRiskBPLoweringMedicine-1",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet AusCVDRiskBPLoweringMedicine-1</b></p><a name=\"AusCVDRiskBPLoweringMedicine-1\"> </a><a name=\"hcAusCVDRiskBPLoweringMedicine-1\"> </a><a name=\"AusCVDRiskBPLoweringMedicine-1-en-AU\"> </a><ul><li>Include codes from<a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where constraint  = ((^929360061000036106|MP| AND &lt;&lt; (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)) OR ( &lt;&lt;^929360071000036103|MPUU| AND &lt;&lt; (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)) OR ( &lt;&lt;^ 929360081000036101|MPP| : { 774160008 |Contains clinical drug| =  &lt;&lt; (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|) }) OR ((( &lt;&lt;^929360071000036103|MPUU| AND &lt;&lt; (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)) OR ( &lt;&lt;^ 929360081000036101|MPP| : { 774160008 |Contains clinical drug| =  &lt;&lt; ( 41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)})) .774158006 |Has product name|)) MINUS ((( &lt;&lt;^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (&lt;&lt;385124005 |Eye drops| OR &lt;&lt;385122009 |Eye gel| OR &lt;&lt;129011000036109 |Injection|)) OR (&lt;&lt;^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = (&lt;&lt;^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (&lt;&lt;385124005 |Eye drops| OR &lt;&lt;385122009 |Eye gel| OR &lt;&lt;129011000036109 |Injection|))}) OR ((( &lt;&lt;^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (&lt;&lt;385124005 |Eye drops| OR &lt;&lt;385122009 |Eye gel| OR &lt;&lt;129011000036109 |Injection|)) OR (&lt;&lt;^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = (&lt;&lt;^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (&lt;&lt;385124005 |Eye drops| OR &lt;&lt;385122009 |Eye gel| OR &lt;&lt;129011000036109 |Injection|)) }) ) .774158006 |Has product name|)) OR ((&lt;&lt;^929360061000036106|MP| AND &lt;&lt;(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|)) OR (&lt;&lt;^ 929360081000036101|MPP|: { 774160008 |Contains clinical drug| =  &lt;&lt;(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|) }) OR (((&lt;&lt;^929360061000036106|MP| AND &lt;&lt;(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|)) OR (&lt;&lt;^ 929360081000036101|MPP|: { 774160008 |Contains clinical drug| =  &lt;&lt;(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|) })) .774158006 |Has product name|)))</li></ul></div>"
      },
      "url" : "https://www.cvdcheck.org.au/fhir/ValueSet/AusCVDRiskBPLoweringMedicine-1",
      "version" : "Iteration3",
      "name" : "AusCVDRiskBPLoweringMedicine",
      "title" : "Aus CVD Risk Blood Pressure Lowering Medicine",
      "status" : "draft",
      "experimental" : false,
      "date" : "2025-05-19T11:57:09+10:00",
      "publisher" : "National Heart Foundation of Australia",
      "contact" : [
        {
          "name" : "National Heart Foundation of Australia",
          "telecom" : [
            {
              "system" : "url",
              "value" : "https://www.heartfoundation.org.au/"
            }
          ]
        }
      ],
      "description" : "The Aus CVD Risk Blood Pressure Lowering Medicine value set includes Australian Medicines Terminology products classified as blood pressure lowering according to the Australian guideline for assessing and managing cardiovascular disease risk.",
      "jurisdiction" : [
        {
          "coding" : [
            {
              "system" : "urn:iso:std:iso:3166",
              "code" : "AU",
              "display" : "Australia"
            }
          ]
        }
      ],
      "copyright" : "Copyright © 2024+ National Heart Foundation of Australia - All rights reserved. This content is not available under an open source licence.",
      "compose" : {
        "include" : [
          {
            "system" : "http://snomed.info/sct",
            "version" : "http://snomed.info/sct/32506021000036107",
            "filter" : [
              {
                "property" : "constraint",
                "op" : "=",
                "value" : "((^929360061000036106|MP| AND << (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)) OR ( <<^929360071000036103|MPUU| AND << (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)) OR ( <<^ 929360081000036101|MPP| : { 774160008 |Contains clinical drug| =  << (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|) }) OR ((( <<^929360071000036103|MPUU| AND << (41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)) OR ( <<^ 929360081000036101|MPP| : { 774160008 |Contains clinical drug| =  << ( 41549009 |Angiotensin-converting enzyme inhibitor-containing product| OR 33252009 |Beta blocker-containing product| OR 45518007 |Thiazide diuretic agent| OR 96308008 |Angiotensin II receptor antagonist-containing product| OR 48698004 |Calcium channel blocker-containing product|)})) .774158006 |Has product name|)) MINUS ((( <<^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (<<385124005 |Eye drops| OR <<385122009 |Eye gel| OR <<129011000036109 |Injection|)) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = (<<^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (<<385124005 |Eye drops| OR <<385122009 |Eye gel| OR <<129011000036109 |Injection|))}) OR ((( <<^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (<<385124005 |Eye drops| OR <<385122009 |Eye gel| OR <<129011000036109 |Injection|)) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = (<<^929360071000036103|MPUU|: 411116001 |Has manufactured dose form| = (<<385124005 |Eye drops| OR <<385122009 |Eye gel| OR <<129011000036109 |Injection|)) }) ) .774158006 |Has product name|)) OR ((<<^929360061000036106|MP| AND <<(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|)) OR (<<^ 929360081000036101|MPP|: { 774160008 |Contains clinical drug| =  <<(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|) }) OR (((<<^929360061000036106|MP| AND <<(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|)) OR (<<^ 929360081000036101|MPP|: { 774160008 |Contains clinical drug| =  <<(108402001 |Gabapentin| OR 77856005 |Esmolol| OR 85591001 |Timolol| OR 349903009 |Levobunolol| OR 87285001 |Nimodipine|) })) .774158006 |Has product name|)))"
              }
            ]
          }
        ]
      }
    }